Exp. Anim., 2023 · DOI: 10.1538/expanim.22-0026 · Published: January 1, 2023
Spinal cord injury (SCI) in dogs often leads to inflammation, worsening the damage. Mesenchymal stem cells (MSCs) can help repair tissue and move to injured areas, making them a promising treatment. Bone marrow peri-adipocyte cells (BM-PACs) from dogs have stem cell properties that are even better than regular bone marrow MSCs. This study tested if BM-PACs can release a growth factor called hepatocyte growth factor (HGF) and move towards inflammation in lab experiments. The study found that BM-PACs can release HGF when exposed to inflammation and can move towards inflammatory signals. The researchers then injected BM-PACs into mice with spinal cord injuries to see if the cells could move to the injury site and help repair the damage. They found that BM-PACs did move to the injured spinal cord, increased HGF levels, and helped the mice recover function, with less tissue damage and scarring compared to mice that did not receive the cells.
Intravenous administration of BM-PACs could be a novel therapeutic strategy for acute canine SCI.
BM-PACs' ability to secrete HGF in response to inflammation and migrate to the injury site contributes to tissue repair and functional recovery.
The findings support further investigation into the use of BM-PACs for treating SCI in dogs, potentially improving outcomes for this common neurological disorder.